Dr. Mark Poznansky, Director, Vaccine and Immunotherapy Center (VIC), and Physician, Infectious Diseases, Massachusetts General Hospital. Associate Professor, Harvard Medical School.
Dr. Poznansky is an expert physician scientist and medical innovator who has combined these expertise together to found and direct the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital to foster accelerated bench to bedside research and the development of novel vaccines and immunotherapies for cancer, infectious and immune mediated diseases. His expertise is in immunology and, in particular, immune cell migration. He discovered fugetaxis, the principle of immuno-repulsion or the active movement of immune cells away from an agent source, that forms the basis of his academic research at Harvard Medical School. His laboratory defined the molecular mechanism for this novel immune process and now explores the relevance of this mechanism to new therapeutic approaches to cancer, infectious diseases and type 1 diabetes. Dr. Poznansky is an Associate Professor of Medicine at Harvard Medical School and Attending Physician in Infectious Diseases Medicine at Massachusetts General Hospital.
Dr. Poznansky will share insights into the most promising clinical trials for Covid-19 Vaccines, plus discuss how these global research initiatives may help stop this and the next Pandemic.
